Developed in the 1980s at the University of Arizona, MT-1 was designed as a more potent and stable version of -MSH for research into melanocortin receptor signaling and skin pigmentation biology
Mechanism of Action : Like Tesamorelin, CJC-1295 works by stimulating the release of growth hormone from the pituitary gland, subsequently increasing IGF-1 levels
The purity and efficacy remain consistently high across batches, and our testing confirms this
There are many free podcasts, webinars and articles to get you started
Stidsen JV, Henriksen JE, Olsen MH.., et al
Nuclear translocation of STAT3 and NF-B are independent of each other but NF-B supports expression and activation of STAT3